Nosocomial infections due to Pseudomonas aeruginosa: review of recent trends.
The role of Pseudomonas aeruginosa in nosocomial infections occurring since 1975 is reviewed. Data from the National Nosocomial Infections Study conducted by the Centers for Disease Control, from individual medical centers, and from the literature were used to compare the relative frequency of occurrence of nosocomial infection caused by P. aeruginosa with that of infection caused by other gram-negative bacilli. The relative frequency of P. aeruginosa as a nosocomial pathogen has increased, although wide variations are seen among individual medical centers. P. aeruginosa continues to be a major pathogen among patients with immunosuppression, cystic fibrosis, malignancy, and trauma. While Staphylococcus aureus has become the predominant pathogen in some large burn centers, P. aeruginosa is the most important gram-negative pathogen. Periodic review of the epidemiology of P. aeruginosa infection is warranted in view of the changing incidence of infection caused by this organism.
D000380:Agranulocytosis / Q000150:complications; D002056:Burns / Q000150:complications; D003428:Cross Infection / Q000453:epidemiology* / Q000382:microbiology; D003550:Cystic Fibrosis / Q000150:complications; D006090:Gram-Negative Bacteria; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D008887:Military Medicine; D009369:Neoplasms / Q000150:complications; D011552:Pseudomonas Infections / Q000453:epidemiology* / Q000382:microbiology; D014481:United States; D014947:Wounds and Injuries / Q000150:complications